Amicus Therapeutics, Inc. (FOLD)
NASDAQ: FOLD · Real-Time Price · USD
14.38
+0.01 (0.03%)
At close: Mar 19, 2026, 4:00 PM EDT
14.38
+0.01 (0.03%)
After-hours: Mar 19, 2026, 6:16 PM EDT

Amicus Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
4,5144,4262,8174,1663,4323,221
Market Cap Growth
65.09%57.14%-32.38%21.38%6.55%-46.76%
Enterprise Value
4,6644,5673,0024,3173,5823,172
Last Close Price
14.3814.249.4214.1912.2111.55
PE Ratio
--158.22-52.33-27.82-14.89-12.55
Forward PE
41.6759.6887.63---
PS Ratio
7.126.985.3310.4310.4310.54
PB Ratio
16.3016.1414.5226.0127.8910.48
P/TBV Ratio
16.1616.0114.7826.1528.6810.20
P/FCF Ratio
151.27148.29-75.23-54.44-20.15-15.61
P/OCF Ratio
136.23133.55-83.12-60.30-20.61-15.91
EV/Sales Ratio
7.357.205.6810.8110.8810.38
EV/EBITDA Ratio
111.18113.4689.82-62.25-17.32-15.84
EV/EBIT Ratio
135.23139.27120.69-55.91-16.89-15.36
EV/FCF Ratio
156.26152.99-80.18-56.40-21.03-15.37
Debt / Equity Ratio
1.581.582.242.733.601.41
Debt / EBITDA Ratio
10.9910.9913.27-6.42-2.19-2.20
Debt / FCF Ratio
14.8214.82-11.85-5.81-2.65-2.13
Net Debt / Equity Ratio
0.540.541.000.991.29-0.14
Net Debt / EBITDA Ratio
3.703.705.80-2.29-0.770.21
Net Debt / FCF Ratio
4.994.99-5.17-2.08-0.930.21
Asset Turnover
0.730.730.680.530.400.34
Inventory Turnover
0.420.420.590.891.521.49
Quick Ratio
1.721.722.362.232.593.67
Current Ratio
2.842.843.392.883.054.09
Return on Equity (ROE)
-11.58%-11.58%-31.68%-107.04%-109.93%-84.37%
Return on Assets (ROA)
-536.51%-536.51%6.21%-10.38%-25.45%-23.89%
Return on Invested Capital (ROIC)
-1132.23%-1132.23%13.35%-23.85%-66.40%-72.27%
Return on Capital Employed (ROCE)
4.86%4.86%3.99%-12.92%-31.56%-27.23%
Earnings Yield
-0.60%-0.63%-1.91%-3.59%-6.72%-7.97%
FCF Yield
0.66%0.67%-1.33%-1.84%-4.96%-6.41%
Buyback Yield / Dilution
-0.02%-0.02%-0.19%-2.05%0.21%-6.65%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q